FDA approves first non-hormonal treatment for hot flashes
Good news for women this week who have delayed getting care for hot flashes out of concern that most treatments contain hormones. The U.S. Food and Drug Administration (FDA), has approved the very first non-hormonal treatment for the menopause-associated flashes.
The new drug, Brisdelle is marketed by Noven Therapeutics, LLC. It is approved to treat moderate to severe hot flashes. Makers of the drug say it contains paroxetine, which is a selective serotonin reuptake inhibitor (SSRI) antidepressant that is sold under the brand names Paxil and Pexeva.
It is important to note that both Paxil and Pexeva carry a warning about an increased risk of suicide in young adults and children. Because Brisdelle contains the same active ingredient, it also has a warning about suicide risk included on its label.
Additionally, there is a warning about a possible reduction in the effectiveness of tamoxifen as well as an increased risk of bleeding when both drugs are taken together. Brisdelle is taken once daily at bedtime.
The FDA says approval of drug was based on two clinical trials that included a total of 1,175 postmenopausal women. Brisdelle was found to be more effective than a placebo at reducing hot flashes. Common side effects included headache, fatigue, nausea and vomiting.
In an online news release, the director of the FDA’s Center for Drug Evaluation and Research, Dr. Hylton Joffe, said, “There are a significant number of women who suffer from hot flashes associated with menopause and who cannot or do not want to use hormonal treatments.”
Right now there are a number of FDA-approved treatments on the market for hot flashes, but all contain either estrogen or estrogen and a progestin.
According to the latest U.S. Census data, there are approximately 37.5 million women reaching or currently at menopause (ages 40 to 59). Menopause-related hot flashes can occur in up to 75 percent of these women and can last for five years or even longer.
While hot flashes are not considered to be a threat to your health, doctors say they can cause extreme discomfort, embarrassment and sleep disruption.
Experts say if you are experiencing menopausal symptoms, you should contact your doctor to develop a treatment plan than can help ease your symptoms.
About the Author
health enews staff is a group of experienced writers from our Advocate Health Care and Aurora Health Care sites, which also includes freelance or intern writers.
In response to your information, Why am I at the age of 65 years? I’m still experiencing the discomfort of menopause and hot flashes everyday especially at night time. According to the latest U.S. Census data, there are approximately 37.5 million women reaching or currently at menopause (ages 40 to 59). Menopause-related hot flashes can occur in up to 75 percent of these women and can last for five years or even longer.
Thanks so much for your question. This is definitely something you should talk with your physician about. The statistic in the article points to CDC data that gives a range of when women approach/reach menopause. As noted in the article, hot flashes can last up to five years and even longer in some women. Again, thanks for reading and sharing your question. Warmest Regards!
In my opinion, the use of a psycho-active drugs such as SSRI anti-depressants for treatment of symptoms caused by menopausal hormone deficiency is an abuse and mistreatment of women belonging in a medical museum as an example of medical iatrogenesis in women.
Not only is paroxetine, Paxil medically ineffective for treatment of menopausal symptoms (a hormone deficiency state), Paroxetine, Paxil is one of the most addictive of the SSRI drugs, with warnings about severe withdrawal effects.
The abuse of women by prescribing psychiatric drugs for menopausal symptoms is a cruel form of abuse and mistreatment which should be halted immediately.
for more http://wp.me/p3gFbV-vs
jeffrey dach md